Pharmaceutical Packaging Market Regional Analysis

Pharmaceutical Packaging Market size was valued at USD 155.56 Billion in 2023 and is poised to grow from USD 170.96 Billion in 2024 to USD 331.05 Billion by 2032, growing at a CAGR of 9.9% during the forecast period (2025-2032).

Pharmaceutical packaging market providers need to focus on maximizing their business scope by reaching into new markets and developing pharmaceutical packaging for different industrial and personal uses. Raising new capital to fund their R&D and business expansion efforts will be essential for new pharmaceutical packaging companies going forward. The development of custom robots for specific applications across different industry verticals will also help companies expand their sales potential in the future.    'Amcor plc (Switzerland)  ', 'Berry Global Inc. (United States)  ', 'Gerresheimer AG (Germany)  ', 'AptarGroup Inc. (United States)  ', 'Schott AG (Germany)  ', 'West Pharmaceutical Services, Inc. (United States)  ', 'Catalent, Inc. (United States)  ', 'Owens-Illinois Inc. (United States)  ', 'WestRock Company (United States)  ', 'Sonoco Products Company (United States)  ', 'Stevanato Group S.p.A. (Italy)  ', 'Nipro Corporation (Japan)  ', 'Comar, LLC (United States)  ', 'SGD Pharma (France)  ', 'Aptargroup, Inc. (United States)  ', 'Drug Plastics & Glass Co., Inc. (United States)  ', 'TricorBraun Holdings, Inc. (United States)  ', 'Bilcare Limited (India)  ', 'Tekni-Plex, Inc. (United States)  ', 'SEALED AIR (US) '

Growing concerns about safety of drugs like problems associated with tampering and counterfeiting is demanding secure packaging solutions like anti-counterfeiting and tamper-evident technologies. In addition, modernizations like smart packaging embedded with features like sensors and RFID tags are increasing adopted by drug producing companies, thereby impacting the pharmaceutical packaging market growth. 

Progress of Pharmacogenomics (PGx): In recent years, deaths due to ADRs (adverse drug reactions) have been fueling research and studies in personalized medicine. Pharmacogenomics or PGx is an innovative healthcare form that tailor treatments at personal level by offering genetically customized dosages and medicines. This reduces adverse drug reactions besides enhancing efficacy of the treatment.

Geographically, North America held the dominant pharmaceutical packaging market share in the previous years and is projected to lead over the forecast period as well owing to well-established pharmaceutical industry, mainly in the developed nations like Canada and the United States. These nations have sophisticated and highly developed pharma industry with key companies operating and a wide range of research and development services. This presence of strong industry is fueling the demand for improved packaging solutions in the region. Also, the region is a hub for innovations and advanced technologies in pharmaceutical packaging, which impacts market growth. The companies operating in North America include Amcor, Westrock, Sonoco, McKesson Corporation, Alpha Packaging, Sealed Air Corporation, and more.